PUBLIC CONTRACT · 2025
1567/2025 - Ajuste direto para aquisição de DP3 - ANTITRIPSINA ALFA 1 (MG), DP15 - IMUNOGLOBULINA HUMANA CONTRA HEPATITE B, IM/SC (UI) e DP24 - IMUNOGLOBULINA HUMANA NORMAL, IM/SC (g)
- Contract value
- €387,199.99
- Signed on
- 10 July 2025
- Procedure
- Direct award, general (Ajuste Direto Regime Geral)
This page lays out the fields published on Portal BASE and says when a field is unavailable. It is not an assessment of the contract's merit, legality or impact.
Record 11594505PUBLISHED SUBJECT
1567/2025 - Ajuste direto para aquisição de DP3 - ANTITRIPSINA ALFA 1 (MG), DP15 - IMUNOGLOBULINA HUMANA CONTRA HEPATITE B, IM/SC (UI) e DP24 - IMUNOGLOBULINA HUMANA NORMAL, IM/SC (g)
Parties involved
- Place of performance
- Portugal
- NUTS region
- PTZZZ - Extra-Regio NUTS 3 (Todos)
WHO BID
Awardee and competitors
Companies that IMPIC lists as the awardee and as competitors in this procedure.
- Awardee
- cls · Tax ID 503047201
Values and timeline
- Contract price
- €387,199.99
- Procedure base price
- €567,488.00
- Total effective price
- Not reported on Portal BASE
- Publication date
- 21 July 2025
- Award date
- 10 July 2025
- Signing date
- 10 July 2025
- Performance period
- 215 days
The contract price is the value agreed in the contract, not the amount paid.
Procedure and framework
- Contract type
- Aquisição de bens móveis
- Procedure type
- Direct award, general (Ajuste Direto Regime Geral)
- Award criterion
- Monofator
- CPV code
- 33600000-6 - Produtos farmacêuticos
- Legal basis
- Artigo 24.º, n.º 1, alínea e), subalínea ii) do Código dos Contratos Públicos
- Regime
- Código dos Contratos Públicos (DL111-B/2017) e Lei n.º 30/2021, de 21.05
- Framework agreement
- Not stated
- Centralised procedure
- Yes
- Environmental criterion
- No
- Notice
- Not stated
- Procedure identifier
- 7649262
Compare with other contracts
Search the same body, supplier, place or type of service to understand the context of the published index.